Some Multiplicity Adjustment Procedures for Clinical Trials with Sequential Design and Multiple Endpoints

被引：0
|
作者：
Luo, Xiaodong [1 ]
Quan, Hui [1 ]
机构：
[1] Sanofi US, Biostat & Programming, 55 Corp Dr, Bridgewater, NJ 08807 USA
来源：
STATISTICS IN BIOPHARMACEUTICAL RESEARCH | 2024年 / 16卷 / 01期
关键词：
Generalized Simes inequality; Group-sequential p-values; Multiplicity; q-values; early submission; alpha-propagation; BONFERRONI PROCEDURE; TESTS;
D O I：
10.1080/19466315.2023.2191989
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
This article proposes some new multiplicity adjustment procedures for clinical trials with multiple endpoints and multiple interim analyses. The proposed sequential procedures, adapting the popular multiple comparison procedures for fixed time-point design and using a-spending for each endpoint, are shown to strongly control the family-wise Type-1 error rate and provide powerful yet versatile multiplicity adjustment solutions for monitoring multiple endpoints via interim analyses.
引用
收藏
页码：104 / 115
页数：12
相关论文
共 50 条
  • [31] Clinical trials: design, endpoints and interpretation of outcomes
    Othus, Megan
    Zhang, Mei-Jie
    Gale, Robert Peter
    BONE MARROW TRANSPLANTATION, 2022, 57 (03) : 338 - 342
  • [32] Design and endpoints of clinical trials in hepatocellular carcinoma
    Llovet, Josep M.
    Di Bisceglie, Adrian M.
    Bruix, Jordi
    Kramer, Barnett S.
    Lencioni, Riccardo
    Zhu, Andrew X.
    Sherman, Morris
    Schwartz, Myron
    Lotze, Michael
    Talwalkar, Jayant
    Gores, Gregory J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (10): : 698 - 711
  • [33] Novel endpoints and design of early clinical trials
    Parulekar, WR
    Eisenhauer, EA
    ANNALS OF ONCOLOGY, 2002, 13 : 139 - 143
  • [34] Design and Endpoints of Clinical Trials, Current and Future
    Morris Sherman
    Digestive Diseases and Sciences, 2019, 64 : 1050 - 1057
  • [35] Tests and confidence intervals for secondary endpoints in sequential clinical trials
    Lai, Tze Leung
    Shih, Mei-Chiung
    Su, Zheng
    BIOMETRIKA, 2009, 96 (04) : 903 - 915
  • [36] A decision rule based multiplicity adjustment strategy in clinical trials
    Chen, X
    Binkowitz, B
    Capizzi, T
    Lou, E
    Quan, H
    Wei, L
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 79S - 80S
  • [37] Allocating recycled significance levels in group sequential procedures for multiple endpoints
    Xi, Dong
    Tamhane, Ajit C.
    BIOMETRICAL JOURNAL, 2015, 57 (01) : 90 - 107
  • [38] Multiplicity Issues in Clinical Trials With Multiple Objectives
    Huque, Mohammad F.
    Dmitrienko, Alex
    D'Agostino, Ralph
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2013, 5 (04): : 321 - 337
  • [39] Bayesian design and analysis of composite endpoints in clinical trials with multiple dependent binary outcomes
    Zaslavsky, Boris G.
    PHARMACEUTICAL STATISTICS, 2013, 12 (04) : 207 - 212
  • [40] Implementing optimal allocation in clinical trials with multiple endpoints
    Wang, Lu
    Chen, Yong
    Zhu, Hongjian
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2017, 182 : 88 - 99
12345